Yasmeen Rahimi
Stock Analyst at Piper Sandler
(4.02)
# 548
Out of 5,049 analysts
82
Total ratings
42.17%
Success rate
16.64%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Yasmeen Rahimi
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PRTA Prothena Corporation | Maintains: Overweight | $15 → $36 | $10.08 | +257.14% | 5 | Oct 28, 2025 | |
| MDGL Madrigal Pharmaceuticals | Maintains: Overweight | $400 → $540 | $488.58 | +10.52% | 4 | Oct 15, 2025 | |
| LBRX LB Pharmaceuticals | Initiates: Overweight | $78 | $15.51 | +402.90% | 1 | Oct 6, 2025 | |
| TENX Tenax Therapeutics | Initiates: Overweight | $20 | $6.92 | +189.02% | 1 | Sep 8, 2025 | |
| IVA Inventiva | Initiates: Overweight | $26 | $4.18 | +522.01% | 1 | Aug 27, 2025 | |
| PLRX Pliant Therapeutics | Maintains: Overweight | $17 → $4 | $1.53 | +161.44% | 2 | Aug 8, 2025 | |
| TVRD Tvardi Therapeutics | Initiates: Overweight | $78 | $3.94 | +1,879.70% | 1 | Jun 12, 2025 | |
| SLNO Soleno Therapeutics | Maintains: Overweight | $93 → $145 | $43.54 | +233.03% | 2 | Apr 24, 2025 | |
| EWTX Edgewise Therapeutics | Maintains: Overweight | $51 | $17.09 | +198.42% | 4 | Apr 2, 2025 | |
| LXRX Lexicon Pharmaceuticals | Maintains: Overweight | $10 → $6 | $1.43 | +319.58% | 2 | Mar 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $48 | $15.42 | +211.28% | 1 | Feb 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $93 | $56.11 | +65.75% | 1 | Jan 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $75 | $23.66 | +216.99% | 1 | Nov 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $105 | $55.12 | +90.49% | 1 | Nov 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $37 | $37.05 | -0.13% | 2 | Sep 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $26 | $3.49 | +644.99% | 2 | Sep 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $28 | $0.70 | +3,893.15% | 3 | Jul 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $97 | $43.49 | +123.04% | 4 | Jul 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $270 | $172.35 | +56.66% | 3 | Jul 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $76 | $18.99 | +300.21% | 1 | Jun 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $25 | $3.94 | +534.52% | 3 | Jun 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $30 | $12.00 | +150.00% | 1 | Jun 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $6 → $12 | $6.88 | +74.42% | 2 | May 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $90 | $4.48 | +1,908.93% | 1 | Apr 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $180 | $32.57 | +452.66% | 2 | Mar 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $15 | $2.31 | +549.35% | 1 | Mar 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $7 → $16 | $3.98 | +302.01% | 2 | Mar 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $80 | $38.20 | +109.42% | 1 | Feb 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $58 → $93 | $33.47 | +177.86% | 3 | Oct 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $28 → $57 | $23.67 | +140.81% | 2 | Oct 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $67 | $7.69 | +771.26% | 1 | Aug 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $35 | $79.78 | -56.13% | 3 | Jul 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $87 | $10.80 | +705.56% | 3 | Feb 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $75 → $175 | $7.10 | +2,364.79% | 4 | Jan 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $50 → $72 | $60.30 | +19.40% | 5 | Jun 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $50 | $9.26 | +439.96% | 1 | Nov 15, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $40 | $1.35 | +2,862.96% | 1 | Aug 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $18 | $0.38 | +4,700.00% | 1 | Jun 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $420 | $15.67 | +2,580.28% | 1 | Aug 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $77 | $8.29 | +828.83% | 1 | Aug 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $77 | $67.72 | +13.70% | 1 | Jul 31, 2020 |
Prothena Corporation
Oct 28, 2025
Maintains: Overweight
Price Target: $15 → $36
Current: $10.08
Upside: +257.14%
Madrigal Pharmaceuticals
Oct 15, 2025
Maintains: Overweight
Price Target: $400 → $540
Current: $488.58
Upside: +10.52%
LB Pharmaceuticals
Oct 6, 2025
Initiates: Overweight
Price Target: $78
Current: $15.51
Upside: +402.90%
Tenax Therapeutics
Sep 8, 2025
Initiates: Overweight
Price Target: $20
Current: $6.92
Upside: +189.02%
Inventiva
Aug 27, 2025
Initiates: Overweight
Price Target: $26
Current: $4.18
Upside: +522.01%
Pliant Therapeutics
Aug 8, 2025
Maintains: Overweight
Price Target: $17 → $4
Current: $1.53
Upside: +161.44%
Tvardi Therapeutics
Jun 12, 2025
Initiates: Overweight
Price Target: $78
Current: $3.94
Upside: +1,879.70%
Soleno Therapeutics
Apr 24, 2025
Maintains: Overweight
Price Target: $93 → $145
Current: $43.54
Upside: +233.03%
Edgewise Therapeutics
Apr 2, 2025
Maintains: Overweight
Price Target: $51
Current: $17.09
Upside: +198.42%
Lexicon Pharmaceuticals
Mar 7, 2025
Maintains: Overweight
Price Target: $10 → $6
Current: $1.43
Upside: +319.58%
Feb 28, 2025
Initiates: Overweight
Price Target: $48
Current: $15.42
Upside: +211.28%
Jan 23, 2025
Initiates: Overweight
Price Target: $93
Current: $56.11
Upside: +65.75%
Nov 5, 2024
Initiates: Overweight
Price Target: $75
Current: $23.66
Upside: +216.99%
Nov 4, 2024
Initiates: Overweight
Price Target: $105
Current: $55.12
Upside: +90.49%
Sep 23, 2024
Reiterates: Overweight
Price Target: $37
Current: $37.05
Upside: -0.13%
Sep 19, 2024
Maintains: Overweight
Price Target: $26
Current: $3.49
Upside: +644.99%
Jul 16, 2024
Reiterates: Overweight
Price Target: $28
Current: $0.70
Upside: +3,893.15%
Jul 2, 2024
Maintains: Overweight
Price Target: $97
Current: $43.49
Upside: +123.04%
Jul 1, 2024
Maintains: Overweight
Price Target: $270
Current: $172.35
Upside: +56.66%
Jun 26, 2024
Initiates: Overweight
Price Target: $76
Current: $18.99
Upside: +300.21%
Jun 21, 2024
Maintains: Overweight
Price Target: $25
Current: $3.94
Upside: +534.52%
Jun 13, 2024
Initiates: Overweight
Price Target: $30
Current: $12.00
Upside: +150.00%
May 7, 2024
Upgrades: Overweight
Price Target: $6 → $12
Current: $6.88
Upside: +74.42%
Apr 4, 2024
Initiates: Overweight
Price Target: $90
Current: $4.48
Upside: +1,908.93%
Mar 27, 2024
Maintains: Overweight
Price Target: $180
Current: $32.57
Upside: +452.66%
Mar 27, 2024
Maintains: Overweight
Price Target: $15
Current: $2.31
Upside: +549.35%
Mar 4, 2024
Maintains: Overweight
Price Target: $7 → $16
Current: $3.98
Upside: +302.01%
Feb 16, 2024
Initiates: Overweight
Price Target: $80
Current: $38.20
Upside: +109.42%
Oct 27, 2023
Maintains: Overweight
Price Target: $58 → $93
Current: $33.47
Upside: +177.86%
Oct 24, 2023
Maintains: Overweight
Price Target: $28 → $57
Current: $23.67
Upside: +140.81%
Aug 8, 2023
Initiates: Overweight
Price Target: $67
Current: $7.69
Upside: +771.26%
Jul 3, 2023
Reiterates: Overweight
Price Target: $35
Current: $79.78
Upside: -56.13%
Feb 8, 2023
Maintains: Overweight
Price Target: $87
Current: $10.80
Upside: +705.56%
Jan 17, 2023
Maintains: Overweight
Price Target: $75 → $175
Current: $7.10
Upside: +2,364.79%
Jun 10, 2022
Maintains: Overweight
Price Target: $50 → $72
Current: $60.30
Upside: +19.40%
Nov 15, 2021
Initiates: Overweight
Price Target: $50
Current: $9.26
Upside: +439.96%
Aug 24, 2021
Initiates: Overweight
Price Target: $40
Current: $1.35
Upside: +2,862.96%
Jun 11, 2021
Initiates: Overweight
Price Target: $18
Current: $0.38
Upside: +4,700.00%
Aug 26, 2020
Initiates: Overweight
Price Target: $420
Current: $15.67
Upside: +2,580.28%
Aug 26, 2020
Initiates: Overweight
Price Target: $77
Current: $8.29
Upside: +828.83%
Jul 31, 2020
Initiates: Overweight
Price Target: $77
Current: $67.72
Upside: +13.70%